Jpb Foundation Eli Lilly & CO Transaction History

Jpb Foundation

$947 Billion
Q3 2024

A detailed history of Jpb Foundation transactions in Eli Lilly & CO stock. As of the latest transaction made, Jpb Foundation holds 43,868 shares of LLY stock, worth $33.1 Million. This represents 4.11% of its overall portfolio holdings.

Number of Shares

43,868

Previous 112,868 61.13%

Holding current value

$33.1 Million

Previous $102 Billion 61.97%

% of portfolio

4.11%

Previous 10.94%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $53.3 Million - $66.2 Million	-69,000 Reduced 61.13%	43,868 $38.9 Billion
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $16.7 Million - $20.9 Million	-23,000 Reduced 16.93%	112,868 $102 Billion
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $9.12 Million - $12.2 Million	-15,400 Reduced 10.18%	135,868 $106 Billion
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $79.4 Million - $93.7 Million	151,268 New	151,268 $88.2 Billion

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpb Foundation, based on Form 13F filings with the SEC.

News

Stay updated on Jpb Foundation with notifications on news.

Account